Learn More Metabolism Supports metabolic health and helps stabilize blood sugar
A 6-month controlled trial in diabetics with ischemic heart disease showed that empagliflozin attenuated both inflammation and systemic oxidative stress, resulting in clinically significant cardiovascular benefits (Ma et al., 2024)
It's a new way to access GLP-1 treatment in a format that may feel more familiar, with studies showing weight loss outcomes comparable to Wegovy injections
While more clinical trials are needed, these early findings suggest a potent role in hormonal resilience and circadian health restoration
On March 5, 2022, Novo Nordisk's world's first basal insulin GLP-1RA injection Xultophy (Insulin Degludec/Liraglutide Injection) was officially launched in China
It works by mimicking a hormone called GLP-1, which regulates blood sugar levels and appetite